# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA711901 | F | In vitro cytotoxic activity against growth of MDR1 transduced line (LCC6-MDR) after 72 hr | Homo sapiens | 5 | ALA1147469 | cell-based format | Scientific Literature | |
2. | ALA711070 | F | Inhibitory activity against the growth of drug resistant LCC6-MDR cell line, human breast carcinoma after 74 hr drug exposure | Homo sapiens | 11 | ALA1136057 | cell-based format | Scientific Literature | |
3. | ALA711072 | F | Cytotoxicity against paclitaxel resistant LCC6-MDR-MDR1 transfected cell line | Homo sapiens | 5 | ALA1133953 | cell-based format | Scientific Literature | |
4. | ALA711073 | F | Inhibitory concentration against LCC6-MDR human breast cancer cell line | Homo sapiens | 5 | ALA1133953 | cell-based format | Scientific Literature | |
5. | ALA711074 | F | Inhibitory concentration against LCC6-MDR human breast cancer cell line; Not determined | Homo sapiens | 1 | ALA1133953 | cell-based format | Scientific Literature | |
6. | ALA711075 | F | Percent reduction of inhibitory concentration against LCC6-MDR human breast cancer cell line at 5 uM concentration | Homo sapiens | 5 | ALA1133953 | cell-based format | Scientific Literature | |
7. | ALA711076 | F | Percent reduction of inhibitory concentration against LCC6-MDR human breast cancer cell line at 5 uM concentration; Not determined | Homo sapiens | 1 | ALA1133953 | cell-based format | Scientific Literature | |
8. | ALA711077 | F | Inhibition of LCC6-MDR human breast carcinoma cell line growth was determined at 1 uM; No growth inhibition | Homo sapiens | 4 | ALA1133953 | cell-based format | Scientific Literature | |
9. | ALA711078 | F | Inhibition of LCC6-MDR human breast carcinoma cell line growth was determined at 5 uM; No growth inhibition | Homo sapiens | 4 | ALA1133953 | cell-based format | Scientific Literature | |
10. | ALA711079 | F | Inhibition of LCC6-MDR-MDR1 transfected cell line growth was determined at 10 uM | Homo sapiens | 3 | ALA1133953 | cell-based format | Scientific Literature | |
11. | ALA711080 | F | Percent reduction of inhibitory concentration against LCC6-MDR human breast cancer cell line at 5 uM concentration | Homo sapiens | 3 | ALA1133953 | cell-based format | Scientific Literature | |
12. | ALA711081 | F | Reversal activity against LCC6-MDR human breast carcinoma cell line | Homo sapiens | 1 | ALA1133953 | cell-based format | Scientific Literature | |
13. | ALA880184 | F | Cytotoxicity against paclitaxel sensitive LCC6-WT-human breast carcinoma cell line | Homo sapiens | 5 | ALA1133953 | cell-based format | Scientific Literature | |
14. | ALA711082 | F | In vitro cytotoxic activity against growth of human breast carcinoma cell line (LCC6-WT) after 72 hr | Homo sapiens | 5 | ALA1147469 | cell-based format | Scientific Literature | |
15. | ALA708862 | F | Inhibitory activity against the growth of wild type LCC6-WT cell line, human breast carcinoma after 74 hr drug exposure | Homo sapiens | 11 | ALA1136057 | cell-based format | Scientific Literature | |
16. | ALA708863 | F | Inhibition of LCC6-WT-human breast carcinoma cell line growth was determined at 10 uM | Homo sapiens | 3 | ALA1133953 | cell-based format | Scientific Literature | |
17. | ALA708657 | F | In vitro cytotoxicity against human breast cancer MDA-MB 435 cell line | Homo sapiens | 10 | ALA1130825 | cell-based format | Scientific Literature | |
18. | ALA709612 | F | Compound was tested for its cytotoxicity against breast MDA-MB-435 Human cancer cell line | Homo sapiens | 1 | ALA1132570 | cell-based format | Scientific Literature | |
19. | ALA709613 | F | 0.048 Antiproliferative activity against human breast MDA-MB-435 cancer cell line | Homo sapiens | 1 | ALA1134683 | cell-based format | Scientific Literature | |
20. | ALA709614 | F | Antiproliferative activity against human breast MDA-MB-435 cancer cell line | Homo sapiens | 22 | ALA1134683 | cell-based format | Scientific Literature |